Amgen
Price & Volume
Stats
See moreOpen | $354.90 |
Previous Close | $351.85 |
Day Range | $352.43-$356.32 |
52W Range | $253.47-$391.29 |
Market Cap | $189.6B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $36.7B |
Revenue Growth (YoY) | 8.6% |
Gross Profit (12 Mos) | $26B |
Diluted EPS | $14.21 |
News
See moreYahoo Finance • 8 hours ago
Renal Cell Carcinoma Market Report 2026-2030 & 2035: Increasing Immunotherapy and Precision Oncology Programs Drives Market Expansion, Reaching USD 6.09 Billion by 2030
Yahoo Finance • 2 days ago
Merck oral PCSK9 enlicitide shows improved cholesterol lowering vs. non-statins
Yahoo Finance • 2 days ago
Viridian Therapeutics Crashes On 'Positive, But Lackluster' Thyroid Eye Disease Results
Yahoo Finance • 2 days ago
How Merck's New Cholesterol Buster Will 'Move The Needle' 'By Removing The Needle'
About
CEO | Mr. Robert A. Bradway |
CFO | Mr. Peter H. Griffith |
Address | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 31,500 |
